Sean Bohen is the founder of Olema Oncology. Olema Oncology has raised $54M in total funding. Latest round: Series C. Based in San Francisco, California.
Sean Bohen is the President and Chief Executive Officer of Olema Oncology, a clinical-stage biopharmaceutical company based in San Francisco. The company focuses on discovering, developing, and commercializing targeted therapies for women's cancers, with a lead product candidate, OP-1250, in breast cancer. Olema Oncology recently raised an $85 million Series C financing round. Prior to joining Olema, Bohen was Executive Vice President of Global Medicines Development and Chief Medical Officer at AstraZeneca and spent 13 years at Genentech.
Full founder directory · Investor directory · Company funding database · Fundraising library